Aktienanalyse zu Aveanna Healthcare Holdings Inc (AVAH)AVAHAveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Aveanna Healthcare Holdings Inc is a good buy right now due to its current price of $13.32, which is below the analyst price targets of $15 and $16, indicating potential upside of 12.7% to 20.1%. Additionally, the stock has shown strong momentum with a year-to-date change of +64.85% and a recent RSI of 63.57, suggesting it is not overbought. However, a key risk is the insider selling activity, which has increased by 675.38% over the last month, indicating potential concerns among insiders about the stock's future performance.